Lion Point Capital, LP Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001643354

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedBuy & Hold how tags are computed

Q1 2024 · 30 positions · Total reported value $109.60M · Top-10 concentration 89.1% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 2.9% · 0 new · 0 cut · 1 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -15.0% · vs SPY -17.1% · Prev Value $20.91M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -3.4% · vs SPY -5.5% · Latest Value $17.26M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q1 2024 13F filing, Lion Point Capital, LP disclosed 30 equity positions with a combined reported value of $109.60M. The filing implies a focused portfolio: its ten largest positions account for 89.1% of reported value. HoldingsHub classifies the profile as Small / Focused / Buy & Hold.

The largest disclosed positions as of Q1 2024 were IWM ($52.05M), MRNS ($19.16M), ARDX ($7.64M). By sector, the heaviest allocations are Health Care 25.8%, Energy 0.1%. Versus the prior quarter, allocation shifted toward Other (+27.6pp), Health Care (+12.1pp) and away from Energy (-1.4pp), Technology (-38.4pp).

Versus the prior quarter, Lion Point Capital, LP opened 0 new positions, trimmed 0 and fully exited 1, a turnover rate of 2.9% of positions. The portfolio's overlap with the prior quarter was 66% of names.

The largest new positions opened in Q1 2024 were XBI ($4.74M), GERN ($1.98M), NBIX ($1.03M).

Of the 1 positions fully exited versus the prior quarter, the largest were HARP ($2.60M), CBAY ($1.95M), AMLX ($206.08K).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2024)

  • XBI SPDR SERIES TRUST · $4.74M
  • GERN GERON CORP · $1.98M
  • NBIX NEUROCRINE BIOSCIENCES INC · $1.03M
  • JSPR JASPER THERAPEUTICS INC · $939.52K
  • MLYS MINERALYS THERAPEUTICS INC · $774.60K
  • RGNX REGENXBIO INC · $684.77K
  • SPRB SPRUCE BIOSCIENCES INC · $58.94K

Fully Exited (vs previous quarter)

  • HARP HARPOON THERAPEUTICS INC · prev qtr: $2.60M
  • CBAY CYMABAY THERAPEUTICS INC · prev qtr: $1.95M
  • AMLX AMYLYX PHARMACEUTICALS INC · prev qtr: $206.08K
  • WHWK WHITEHAWK THERAPEUTICS INC · prev qtr: $166.49K
  • ACRS ACLARIS THERAPEUTICS INC · prev qtr: $121.69K

Insider Transactions (Form 4)

Latest Lion Point Capital, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Lion Point Capital, LP is an SEC-registered 13F filer based in New York, NY, United States. As of Q3 2026 it reported 34 US equity positions with a combined value of $17.26M. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-81004 (status: Approved), registered 2015-02-25
  • Regulatory AUM (Form ADV): $480.60M as of 2026-04-30
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 5 private funds, of which 2 hedge funds
  • Website: lionpoint.com

Portfolio Structure

  • 34 positions · $17.26M reported value (Q3 2026)
  • Top 10 holdings = 56.1% of reported value
  • Largest position: CUE (CUE BIOPHARMA INC) at 7.9%
  • Average position size: $507.68K

Sector Tilt

  • Health Care 98.0%
  • Information Technology 2.0%
  • (classified holdings cover 100% of value)

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 25.8%
Energy 0.1%
Technology 0.1%
Other 74.1%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 247.50K $52.05M 47.49%
47.49%
Add
2 2.12M $19.16M 17.48%
17.48%
Reduce
3 1.05M $7.64M 6.97%
6.97%
Reduce
4 50.00K $4.74M 4.33%
4.33%
New
5 2.30M $4.12M 3.76%
3.76%
Add
6 130.69K $2.58M 2.35%
2.35%
Hold
7 600.00K $1.98M 1.81%
1.81%
New
8 70.33K $1.91M 1.74%
1.74%
Hold
9 170.00K $1.89M 1.73%
1.73%
Add
10 2.75M $1.59M 1.45%
1.45%
Hold
11 65.00K $1.55M 1.41%
1.41%
Add
12 82.50K $1.39M 1.27%
1.27%
Add
13 45.00K $1.13M 1.03%
1.03%
Add
14 848.26K $1.09M 0.99%
0.99%
Add
15 7.50K $1.03M 0.94%
0.94%
New
16 32.00K $939.52K 0.86%
0.86%
New
17 78.12K $845.31K 0.77%
0.77%
Hold
18 60.00K $774.60K 0.71%
0.71%
New
19 235.00K $730.85K 0.67%
0.67%
Hold
20 32.50K $684.77K 0.62%
0.62%
New
21 78.00K $601.38K 0.55%
0.55%
Reduce
22 42.50K $347.23K 0.32%
0.32%
Hold
23 340.76K $263.78K 0.24%
0.24%
Hold
24 90.79K $256.04K 0.23%
0.23%
Hold
25 19.93K $112.78K 0.10%
0.10%
Reduce
26 2.08M $81.25K 0.07%
0.07%
Hold
27 75.00K $58.94K 0.05%
0.05%
New
28 100 $42.07K 0.04%
0.04%
Hold
29 100 $15.23K 0.01%
0.01%
Hold
30 14 $385 0.00%
0.00%
Reduce

FAQ

What did Lion Point Capital, LP buy in 2024-Q1?

In its 2024-Q1 13F filing, Lion Point Capital, LP reported 30 equity positions worth $109.60M in aggregate; its largest disclosed positions were IWM ($52.05M), MRNS ($19.16M), ARDX ($7.64M).

How large is Lion Point Capital, LP's portfolio?

Lion Point Capital, LP reported $109.60M of long equity holdings across 30 positions as of 2024-Q1. Top-10 holdings account for 89.1% of reported value.

What is Lion Point Capital, LP's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Buy & Hold, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/lion-point-capital/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →